U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06932393) titled 'Exosomes for Hairloss Treatment' on April 09.
Brief Summary: Many people suffer from alopecia, which is caused by hereditary factors, emotional stress, and psychiatric disorders. There are devastating physical and psychological consequences as a result. Exosomes are isolated from donated human mesenchymal stem cells and purified using specific processing. This study is a randomized, double-blind, dose-escalation clinical trial designed to evaluate the efficacy and safety of exosomes therapy for alopecia.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Hair Loss
Intervention:
BIOLOGICAL: exosomes
Each subject...